Table 5.
Phenotype | Allele | Discovery | Replication I | Replication II | All subjects | ||||
---|---|---|---|---|---|---|---|---|---|
OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | ||
Lobar ICH Mortality | APOE ε2 | 1·60 (1·13 – 2·25) | 0·008 | 1·52 (1·06 – 2·17) | 0·011 | 1·40 (1·01 – 1·93) | 0·043 | 1·50 (1·23 – 1·82) | 2·45 × 10−5 |
APOE ε4 | 1·18 (0·85 – 1·64) | 0·10 | 1·25 (0·74 – 2·12) | 0·15 | 1·01 (0·73– 1·39) | 0·95 | 1·12 (0·90 – 1·38) | 0·31 | |
Deep ICH Mortality | APOE ε2 | 0·68 (0·29 – 1·57) | 0·36 | 1·11 (0·74 – 1·66) | 0·78 | 0·90 (0·50 – 1·61) | 0·72 | 0·98 (0·72 – 1·34) | 0·90 |
APOE ε4 | 1·20 (0·52 – 2·78) | 0·67 | 1·34 (0·83 – 2·18) | 0·23 | 1·69 (0·52 – 5·48) | 0·38 | 1·34 (0·91 – 1·99) | 0·14 | |
Lobar ICH Poor Outcome* | APOE ε2 | 1·47 (1·10 – 2·0) | 0·009 | 1·67 (1·15 – 2·43) | 0·007 | 1·46 (1·02 – 2·65) | 0·039 | 1·52 (1·25 – 1·85) | 1·74 × 10−5 |
APOE ε4 | 1·24 (0·83 – 1·85) | 0·08 | 1·21 (0·80 – 1·85) | 0·13 | 1·00 (0·79 – 1·26) | 0·99 | 1·08 (0·90 – 1·30) | 0·39 | |
Deep ICH Poor Outcome* | APOE ε2 | 0·71 (0·41 – 1·25) | 0·24 | 1·05 (0·68 – 1·63) | 0·81 | 0·66 (0·26 – 1·67) | 0·38 | 0·87 (0·63 – 1·20) | 0·40 |
APOE ε4 | 1·24 (0·59 – 2·61) | 0·57 | 1·14 (0·76 – 1·71) | 0·52 | 1·15 (0·27 – 4·90) | 0·85 | 1·61 (0·82 – 1·64) | 0·40 |
Defined as modified Rankin Scale 3 – 6 at 90 days post-ICH
OR = Odds Ratio, ICH = Intracerebral Hemorrhage, 95% CI = 95% Confidence Interval